Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.128 AUD | -1.10% | -0.88% | -23.47% |
06/06 | Healthco Healthcare And Wellness REIT Posts 2.3% Valuation Gain, Reaffirms Fiscal 2024 FFO Guidance | MT |
23/04 | Healthco Healthcare And Wellness REIT Plans AU$50 Million On-Market Buyback | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company's share price in relation to its net book value makes it look relatively cheap.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-23.47% | 427M | - | ||
+14.20% | 61.57B | A- | ||
+1.71% | 20.48B | A- | ||
-0.76% | 13.83B | A | ||
+9.59% | 8.3B | B | ||
-5.86% | 6.19B | B- | ||
+11.89% | 3.62B | C- | ||
+4.84% | 3.46B | C+ | ||
-8.64% | 2.97B | B+ | ||
+20.54% | 2.92B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HCW Stock
- Ratings HealthCo Healthcare and Wellness REIT